Bicara Therapeutics Inc.

BCAX

Form 4 • Statement of Changes in Beneficial Ownership

SEC Accession Number: 0001628280-26-015419
Filing date: Mar 5, 2026
Earliest execution date: Mar 3, 2026

Summary

Type

Sell

Net shares

-16,500

% of shares

-12.98%

Amount (USD)

$305,610

Insider confidence score

25.0 out of 100

Positive

  • Under Rule 10b5-1 trading plan

Negative

  • Major scheduled sell (<15% of shares)
  • Large sell amount ($250K+)

Stock transactions

Transaction 1

Security

Common Stock

Action

Exercise

Date

2026-03-03

Code

M

Net shares

+200.0

Price per Share

$3.79

Amount (USD)

$757.96

Acquired/Disposed

Acquired

Shares Owned Before

55,286.0

Shares Owned After

55,486.0

Transaction 2

Security

Common Stock

Action

Sell

Date

2026-03-03

Code

S

Net shares

-200.0

Price per Share

$18.45

Amount (USD)

$3,690.00

Acquired/Disposed

Disposed

Shares Owned Before

55,486.0

Shares Owned After

55,286.0

Transaction 3

Security

Common Stock

Action

Exercise

Date

2026-03-04

Code

M

Net shares

+16,300.0

Price per Share

$3.79

Amount (USD)

$61,773.74

Acquired/Disposed

Acquired

Shares Owned Before

55,286.0

Shares Owned After

71,586.0

Transaction 4

Security

Common Stock

Action

Sell

Date

2026-03-04

Code

S

Net shares

-16,300.0

Price per Share

$18.52

Amount (USD)

$301,920.01

Acquired/Disposed

Disposed

Shares Owned Before

71,586.0

Shares Owned After

55,286.0

Derivative Transactions

Transaction 1

Security

Stock Option (Right to Buy)

Action

Exercise

Date

2026-03-03

Code

M

Net shares

-200.0

Acquired/Disposed

Disposed

Shares Owned Before

69,413.0

Shares Owned After

69,213.0

Transaction 2

Security

Stock Option (Right to Buy)

Action

Exercise

Date

2026-03-04

Code

M

Net shares

-16,300.0

Acquired/Disposed

Disposed

Shares Owned Before

69,213.0

Shares Owned After

52,913.0

Filing's footnotes

1. This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025.

2. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $18.45 to $18.72, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.

3. The shares underlying this option vest in sixteen equal quarterly installments following August 8, 2023, subject to the Reporting Person's continued service on each such vesting date.

ℹ️ Filed under Rule 10b5-1 trading plan

This page is for informational purposes only. While we strive for accuracy, the summary may contain inaccuracies or omissions. Please refer to the official SEC filing for authoritative information. Open the SEC filing.